Latest Form 4 insider transactions

Howard I Ungerleider, a Director of Kyndryl Holdings, Inc., received 17,844 shares of common stock on July 30, 2026.

Daniel Gizinski, President, S&S Comm. Segment of Comtech Telecommunications Corp /De/, reported multiple transactions in common stock on July 31, 2026.

Nikhil Ramesh Mehta, a Director of F5, Inc., sold 4,000 shares of common stock on July 30, 2026.

Jana R Schreuder, a Director of Kyndryl Holdings, Inc., received 17,844 shares of common stock on July 30, 2026.

Stephen T. Higgins, EVP & CAO of Freeport-Mcmoran Inc, sold 7,550 shares of common stock on July 30, 2026 for $63.00 per share.

Kurt James Wolf, President & CEO and a Director of Pitney Bowes Inc /De/, reported multiple transactions in common stock on August 3, 2026.

Kurt James Wolf, President & CEO and a Director of Pitney Bowes Inc /De/, sold 1,055,192 shares of common stock on July 30, 2026.

Anthony Mathew Eisen, a Director of Block, Inc., sold 18,000 shares of common stock on July 30, 2026.

Michael Carrosino, EVP of Finance & CFO of Heritage Distilling Holding Company, Inc., reported multiple transactions in common stock on August 2, 2026.

Jennifer D H Stiefel, President & Secretary and a Director of Heritage Distilling Holding Company, Inc., reported multiple transactions in common stock on August 2, 2026.

Justin B Stiefel, CEO & Treasurer and a Director of Heritage Distilling Holding Company, Inc., reported multiple transactions in common stock on August 2, 2026.

Scott Mezvinsky, KFC Division CEO of Yum Brands Inc, sold 268 shares of common stock on August 3, 2026 for $153.15 per share.

5AM Ventures V, L.P. and 5 others reported changes in beneficial ownership of Entrada Therapeutics, Inc. common stock on July 30, 2026.

Stephen A. M. Hester, a Director of Kyndryl Holdings, Inc., reported multiple transactions in common stock on July 30, 2026.

Debbie Sharell Roberts, a Director of Rli Corp, reported a transaction in 408 shares of common stock on July 31, 2026.

Paul Bennett Medini, a Director of Rli Corp, reported a transaction in 471 shares of common stock on July 31, 2026.

Paul J Taubman, Chairman and CEO and a Director of PJT Partners Inc., reported a transaction in 36,000 shares of common stock on July 30, 2026.

G Courtney Haning, a Director of Rocky Brands, Inc., sold 3,000 shares of common stock on July 30, 2026 for $49.06 per share.

Tracie A. Winbigler, a Director of Rocky Brands, Inc., sold 3,000 shares of common stock on July 31, 2026 for $47.45 per share.

William L Jordan, a Director of Rocky Brands, Inc., sold 2,011 shares of common stock on July 31, 2026 for $48.48 per share.

Dwight Eric Smith, a Director of Rocky Brands, Inc., purchased 500 shares of common stock on July 30, 2026 for $48.63 per share.

Curtis A Loveland, Assistant Secretary and a Director of Rocky Brands, Inc., sold 3,000 shares of common stock on June 5, 2026 for $49.62 per share.

Garo H Armen, EXEC. CHAIR & PRINCIPAL OFF. and a Director of Protagenic Therapeutics, Inc.new, purchased 26,291 shares of common stock on July 30, 2026 for $0.18 per share.

Cindy Lee, Chief Financial Officer of Virtu Financial, Inc., reported multiple transactions in common stock on August 1, 2026.

Kush Parmar, a Director and 10% owner of Entrada Therapeutics, Inc., sold 116,474 shares of common stock on July 30, 2026.

Christopher Lee Turner, Chief Executive Officer and a Director of Yum Brands Inc, sold 261 shares of common stock on August 3, 2026 for $153.15 per share.

Janina Kugel, a Director of Kyndryl Holdings, Inc., reported multiple transactions in common stock on July 30, 2026.

Indivior and Supernus Pharmaceuticals announce an all-stock merger of equals to create a leading U.S. biopharmaceutical company focused on central nervous system diseases.

Indivior and Supernus Pharmaceuticals announce an all-stock merger of equals to create a leading U.S. biopharmaceutical company focused on central nervous system diseases.

Scott T Crawley, Controller & Prin Actg Officer of First Financial Bancorp /Oh/, sold 2,700 shares of common stock on August 3, 2026 for $34.16 per share.